PreferaOB ® Prenatal/Postnatal Multivitamin/ Multimineral Tablets

Manufacturer: Alaven Pharmaceutical LLC | Nexgen Pharma Inc.
Effective date: 2010-09-13
Label type: HUMAN PRESCRIPTION DRUG LABEL
Version: 1
Source: legacy-cache
Hydrated at: 2026-08-02 01:52:19

Label at a glance#

ProductPreferaOB

Active ingredientFOLIC ACID, Heme Iron Polypeptide, IRON DEXTRAN, Potassium Iodide, Zinc Oxide, Selenium, CUPRIC SULFATE, CHOLECALCIFEROL, THIAMINE MONONITRATE, ALPHA-TOCOPHEROL SUCCINATE, D-, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, BIOTIN, CALCIUM PANTOTHENATE

Label structure11 sections

Boxed warning

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children . In case of accidental overdose, call a doctor or poison control center immediately.

Indications and uses

PreferaOB ® is a prescription multivitamin/multimineral nutritional supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. PreferaOB ® is also beneficial in improving the nutritional status of women prior to conception.

Dosage and administration

One tablet daily with or without food, or as prescribed by a licensed health care provider with prescribing authority.

Contacts and useful links#

PhoneLabel contact1-888-317-0001

Websitewww.preferaob.com

www.PreferaOB.com

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx Only

DESCRIPTION

DESCRIPTION SECTION

PreferaOB^® is a prescription prenatal/postnatal multivitamin/multimineral nutritional supplement. PreferaOB^® is a small, oval, film-coated, purple tablet with black core, debossed and bisected with "AP/84" on one side, and plain on the other.

Each PreferaOB^® tablet contains: VITAMINS
D₃ (as cholecalciferol)	400 IU
E (as d-alpha tocopheryl succinate)	10 IU
B₁ (as thiamin mononitrate)	1.5 mg
B₂ (as riboflavin)	1.6 mg
B₃ (niacin as niacinamide)	17 mg
B₆ (as pyridoxine HCl)	50 mg
Folic Acid	1 mg
B₁₂ (as cyanocobalamin)	12 mcg
Biotin	30 mcg
B₅ (as d-calcium pantothenate)	10 mg
MINERALS
Iron
as Polysaccharide Iron Complex (a complex of iron, glucose, maltose, and dextrin; Iron Content ~ 46%) yielding	28 mg
as HIP (heme iron polypeptide as Proferrin^®*- bovine source, USDA certified) yielding	6 mg
Iodine (as potassium iodide)	250 mcg
Zinc (as zinc oxide)	4.5 mg
Selenium (as sodium selenate)	65 mcg
Copper (as cupric sulfate)	0.8 mg

INACTIVE INGREDIENTS: Microcrystalline cellulose, croscarmellose sodium, crospovidone, magnesium stearate, silicon dioxide, dextran, dicalcium phosphate, sucrose, protease, modified food starch, dl-alpha tocopherol, sodium ascorbate, ethylcellulose, resin, coating (polyvinyl alcohol, polyethylene glycol, talc, titanium dioxide, D&C red no. 30 aluminum lake, FD&C blue no. 2 aluminum lake).

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

PreferaOB^® is a prescription multivitamin/multimineral nutritional supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. PreferaOB^® is also beneficial in improving the nutritional status of women prior to conception.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

WARNING

BOXED WARNING SECTION

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

PRECAUTIONS

PRECAUTIONS SECTION

Folic acid when administered as a single agent in doses above 0.1 mg daily may obscure pernicious anemia in that hematological remission can occur while neurological manifestations remain progressive. Pregnant women and nursing mothers should avoid supplemental doses of vitamin E higher than RDA amounts. While prescribing this nutritional supplement for pregnant women, nursing mothers, or for women prior to conception, their medical condition and other drugs, herbs, and/or supplements consumption should be considered.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

One tablet daily with or without food, or as prescribed by a licensed health care provider with prescribing authority.

HOW SUPPLIED

HOW SUPPLIED SECTION

PreferaOB^® is supplied in a child-resistant bottle of 90 tablets (NDC 68220-084-90) and as a Professional Sample (NDC 68220-084-25).

KEEP OUT OF REACH OF CHILDREN.

STORAGE

STORAGE AND HANDLING SECTION

Store at controlled room temperature 20°-25°C (68°-77°F). Excursions permitted to 15°-30°C (59°-86°F). [See current USP]

Dispense in a tight, light-resistant container to protect from light and moisture.

For medical inquiries call toll free 1-888-317-0001

SPL UNCLASSIFIED SECTION

www.PreferaOB.com

Manufactured for:
ALAVEN ^®
PHARMACEUTICAL LLC
Marietta, GA.

U.S. Patent No. 7,585,527

*Proferrin^® is a registered trademark of Colorado Biolabs, Inc., Cozad, NE.
PreferaOB^® is a registered trademark of Alaven Pharmaceutical LLC,
Marietta, GA 30062

6-084-90-03-0710CR
CL6-084-00-01-0710a

PRINCIPAL DISPLAY PANEL - 90 Tablet Bottle Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 68220-084-90
90 Tablets

PreferaOB^®

www.PreferaOB.com

Manufactured for:
ALAVEN ^®
PHARMACEUTICAL LLC
Marietta, GA 30062

Rx Only

PRINCIPAL DISPLAY PANEL - 90 Tablet Bottle Label

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68220-084-90	2020-02-04	C162847	48780-1	9d75b9cf-ffbc-f424-e053-dadaa90a57ce	PreferaOB ® Prenatal/Postnatal Multivitamin/ Multimineral Tablets
68220-084-90	2020-01-31	C162847	48780-1	9d75b9cf-ffbc-f424-e053-dadaa90a57ce	PreferaOB ® Prenatal/Postnatal Multivitamin/ Multimineral Tablets

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
68220-084-90	EA - Each	68220-084	a8b4fd78-64e0-41d7-918f-dc96d888404e	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ALPHA-TOCOPHEROL SUCCINATE, D-	ACTIVE INGREDIENT	LU4B53JYVE	1
BIOTIN	ACTIVE INGREDIENT	6SO6U10H04	1
CALCIUM PANTOTHENATE	ACTIVE INGREDIENT	568ET80C3D	1
CHOLECALCIFEROL	ACTIVE INGREDIENT	1C6V77QF41	1
CUPRIC SULFATE	ACTIVE INGREDIENT	LRX7AJ16DT	1
CYANOCOBALAMIN	ACTIVE INGREDIENT	P6YC3EG204	1
FOLIC ACID	ACTIVE INGREDIENT	935E97BOY8	1
Heme Iron Polypeptide	ACTIVE INGREDIENT	31VDO12CJY	1
IRON DEXTRAN	ACTIVE INGREDIENT	95HR524N2M	1
NIACINAMIDE	ACTIVE INGREDIENT	25X51I8RD4	1
Potassium Iodide	ACTIVE INGREDIENT	1C4QK22F9J	1
PYRIDOXINE HYDROCHLORIDE	ACTIVE INGREDIENT	68Y4CF58BV	1
RIBOFLAVIN	ACTIVE INGREDIENT	TLM2976OFR	1
Selenium	ACTIVE INGREDIENT	H6241UJ22B	1
THIAMINE MONONITRATE	ACTIVE INGREDIENT	8K0I04919X	1
Zinc Oxide	ACTIVE INGREDIENT	SOI2LOH54Z	1
ALPHA-TOCOPHEROL SUCCINATE, D-	ACTIVE MOIETY	LU4B53JYVE	1
BIOTIN	ACTIVE MOIETY	6SO6U10H04	1
CALCIUM PANTOTHENATE	ACTIVE MOIETY	568ET80C3D	1
CHOLECALCIFEROL	ACTIVE MOIETY	1C6V77QF41	1
CUPRIC CATION	ACTIVE MOIETY	8CBV67279L	1
CYANOCOBALAMIN	ACTIVE MOIETY	P6YC3EG204	1
FOLIC ACID	ACTIVE MOIETY	935E97BOY8	1
Heme Iron Polypeptide	ACTIVE MOIETY	31VDO12CJY	1
IRON DEXTRAN	ACTIVE MOIETY	95HR524N2M	1
NIACINAMIDE	ACTIVE MOIETY	25X51I8RD4	1
POTASSIUM CATION	ACTIVE MOIETY	295O53K152	1
PYRIDOXINE	ACTIVE MOIETY	KV2JZ1BI6Z	1
RIBOFLAVIN	ACTIVE MOIETY	TLM2976OFR	1
Selenium	ACTIVE MOIETY	H6241UJ22B	1
THIAMINE	ACTIVE MOIETY	X66NSO3N35	1
Zinc Oxide	ACTIVE MOIETY	SOI2LOH54Z	1
.ALPHA.-TOCOPHEROL ACETATE, DL-	INACTIVE INGREDIENT	WR1WPI7EW8	1
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	1
ANHYDROUS DIBASIC CALCIUM PHOSPHATE	INACTIVE INGREDIENT	L11K75P92J	1
ASPERGILLUS FLAVUS VAR. ORYZAE PROTEASE	INACTIVE INGREDIENT	Z3GVO2327F	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	1
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	1
D&C RED NO. 30	INACTIVE INGREDIENT	2S42T2808B	1
DEXTRAN 1	INACTIVE INGREDIENT	I8LHQ0D645	1
ETHYLCELLULOSE	INACTIVE INGREDIENT	7Z8S9VYZ4B	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	1
MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE)	INACTIVE INGREDIENT	461P5CJN6T	1
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	1
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	1
SODIUM ASCORBATE	INACTIVE INGREDIENT	S033EH8359	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 2 · 42 matching rows.

PreferaOB
FOLIC ACID, Heme Iron Polypeptide, IRON DEXTRAN, Potassium Iodide, Zinc Oxide, Selenium, CUPRIC SULFATE, CHOLECALCIFEROL, THIAMINE MONONITRATE, ALPHA-TOCOPHEROL SUCCINATE, D-, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, BIOTIN, and CALCIUM PANTOTHENATE
FOLIC ACID
Heme Iron Polypeptide
IRON DEXTRAN
Potassium Iodide
POTASSIUM CATION
Zinc Oxide
Selenium
CUPRIC SULFATE
CUPRIC CATION
CHOLECALCIFEROL
THIAMINE MONONITRATE
THIAMINE
ALPHA-TOCOPHEROL SUCCINATE, D-
RIBOFLAVIN
NIACINAMIDE
PYRIDOXINE HYDROCHLORIDE
PYRIDOXINE
CYANOCOBALAMIN
BIOTIN
CALCIUM PANTOTHENATE
CELLULOSE, MICROCRYSTALLINE
CROSCARMELLOSE SODIUM
MAGNESIUM STEARATE
SILICON DIOXIDE
CROSPOVIDONE
DEXTRAN 1
ANHYDROUS DIBASIC CALCIUM PHOSPHATE
SUCROSE
ASPERGILLUS FLAVUS VAR. ORYZAE PROTEASE
MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE)
.ALPHA.-TOCOPHEROL ACETATE, DL-
SODIUM ASCORBATE
ETHYLCELLULOSE
POLYVINYL ALCOHOL
POLYETHYLENE GLYCOL
TALC
TITANIUM DIOXIDE
D&C RED NO. 30

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
68220-084	68220-084-90

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 36 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
FOLIC ACID	935E97BOY8	ACTIB
Heme Iron Polypeptide	31VDO12CJY	ACTIB
IRON DEXTRAN	95HR524N2M	ACTIB
Potassium Iodide	1C4QK22F9J	ACTIB
Zinc Oxide	SOI2LOH54Z	ACTIB
Selenium	H6241UJ22B	ACTIB
CUPRIC SULFATE	LRX7AJ16DT	ACTIB
CHOLECALCIFEROL	1C6V77QF41	ACTIB
THIAMINE MONONITRATE	8K0I04919X	ACTIB
ALPHA-TOCOPHEROL SUCCINATE, D-	LU4B53JYVE	ACTIB
RIBOFLAVIN	TLM2976OFR	ACTIB
NIACINAMIDE	25X51I8RD4	ACTIB
PYRIDOXINE HYDROCHLORIDE	68Y4CF58BV	ACTIB
CYANOCOBALAMIN	P6YC3EG204	ACTIB
BIOTIN	6SO6U10H04	ACTIB
CALCIUM PANTOTHENATE	568ET80C3D	ACTIB
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT
CROSCARMELLOSE SODIUM	M28OL1HH48	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
CROSPOVIDONE	68401960MK	IACT
DEXTRAN 1	I8LHQ0D645	IACT
ANHYDROUS DIBASIC CALCIUM PHOSPHATE	L11K75P92J	IACT
SUCROSE	C151H8M554	IACT
ASPERGILLUS FLAVUS VAR. ORYZAE PROTEASE	Z3GVO2327F	IACT
MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE)	461P5CJN6T	IACT
.ALPHA.-TOCOPHEROL ACETATE, DL-	WR1WPI7EW8	IACT
SODIUM ASCORBATE	S033EH8359	IACT
ETHYLCELLULOSE	7Z8S9VYZ4B	IACT
POLYVINYL ALCOHOL	532B59J990	IACT
POLYETHYLENE GLYCOL	3WJQ0SDW1A	IACT
TALC	7SEV7J4R1U	IACT
TITANIUM DIOXIDE	15FIX9V2JP	IACT
D&C RED NO. 30	2S42T2808B	IACT
FD&C BLUE NO. 2	L06K8R7DQK	IACT
ALUMINUM OXIDE	LMI26O6933	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 6 · 338 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
ANHYDROUS DIBASIC CALCIUM PHOSPHATE	ANHYDROUS DIBASIC CALCIUM PHOSPHATE	L11K75P92J	PASTILLE / ORAL	NA		Exact identifier — unii candidate 15 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CAPSULE, DELAYED RELEASE / ORAL		1060 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
ETHYLCELLULOSE	ETHYLCELLULOSE	7Z8S9VYZ4B	POWDER / ORAL		2090 mg	Exact identifier — unii candidate 14 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	SYSTEM / TRANSDERMAL		35 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / SUBLINGUAL	17.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
FD&C BLUE NO. 2	FD&C BLUE NO. 2	L06K8R7DQK	SOAP / TOPICAL	NA		Exact identifier — unii candidate 11 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, LIQUID FILLED / ORAL		106 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / SUBLINGUAL		10 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER / RESPIRATORY (INHALATION)	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
SODIUM ASCORBATE	SODIUM ASCORBATE	S033EH8359	CAPSULE / ORAL		6 mg	Exact identifier — unii candidate 7 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	GRANULE, FOR SUSPENSION / ORAL		278 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
ANHYDROUS DIBASIC CALCIUM PHOSPHATE	ANHYDROUS DIBASIC CALCIUM PHOSPHATE	L11K75P92J	TABLET, FILM COATED / ORAL		1075 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL		980 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
CROSCARMELLOSE SODIUM	CROSCARMELLOSE SODIUM	M28OL1HH48	TABLET, DELAYED RELEASE PARTICLES / ORAL		64 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET / BUCCAL	15 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
POLYVINYL ALCOHOL	POLYVINYL ALCOHOL	532B59J990	TABLET, ORALLY DISINTEGRATING / ORAL		2 mg	Exact identifier — unii candidate 17 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	900 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
D&C RED NO. 30	D&C RED NO. 30	2S42T2808B	TABLET, FILM COATED / ORAL	0.26 mg		Exact identifier — unii candidate 7 equally ranked IID candidates
CROSCARMELLOSE SODIUM	CROSCARMELLOSE SODIUM	M28OL1HH48	INJECTION / INTRAMUSCULAR	1 %w/v		Exact identifier — unii candidate 22 equally ranked IID candidates
CROSCARMELLOSE SODIUM	CROSCARMELLOSE SODIUM	M28OL1HH48	TABLET, EXTENDED RELEASE / ORAL		392 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, CHEWABLE / ORAL		1725 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET / SUBLINGUAL	43.2 mg		Exact identifier — unii candidate 28 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		308 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	INSERT / VAGINAL		8 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	DROPS / ORAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
D&C RED NO. 30	D&C RED NO. 30	2S42T2808B	TABLET, CHEWABLE / ORAL		3 mg	Exact identifier — unii candidate 7 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, FOR SOLUTION / ORAL	1.8 mg/120ml		Exact identifier — unii candidate 49 equally ranked IID candidates
ANHYDROUS DIBASIC CALCIUM PHOSPHATE	ANHYDROUS DIBASIC CALCIUM PHOSPHATE	L11K75P92J	TABLET, CHEWABLE / ORAL	50 mg		Exact identifier — unii candidate 15 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	CAPSULE, DELAYED RELEASE / ORAL		420 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	SOLUTION / ORAL		336 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SODIUM ASCORBATE	SODIUM ASCORBATE	S033EH8359	INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS	0.5 mg		Exact identifier — unii candidate 7 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TROCHE / ORAL		315 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	GRANULE / ORAL		629 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER, FOR SUSPENSION / ORAL		2553 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
CROSCARMELLOSE SODIUM	CROSCARMELLOSE SODIUM	M28OL1HH48	GRANULE, FOR SUSPENSION / ORAL		282 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	INHALANT / ORAL	0.08 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	SOAP / TOPICAL	1 %w/w		Exact identifier — unii candidate 40 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	POWDER, FOR SUSPENSION / ORAL		297 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, FOR SUSPENSION / ORAL		131 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	CAPSULE, EXTENDED RELEASE / ORAL		67 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
SODIUM ASCORBATE	SODIUM ASCORBATE	S033EH8359	INJECTION / INTRAVENOUS		625 mg	Exact identifier — unii candidate 7 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING / ORAL		187 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
ANHYDROUS DIBASIC CALCIUM PHOSPHATE	ANHYDROUS DIBASIC CALCIUM PHOSPHATE	L11K75P92J	PASTE, DENTIFRICE / DENTAL	48.36 %w/w		Exact identifier — unii candidate 15 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET / SUBLINGUAL	32.4 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, FILM COATED / ORAL		992 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / BUCCAL		3 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, ORALLY DISINTEGRATING / ORAL		68 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, FOR SUSPENSION / ORAL		24 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
FD&C BLUE NO. 2	FD&C BLUE NO. 2	L06K8R7DQK	TABLET, CHEWABLE / ORAL		3 mg	Exact identifier — unii candidate 11 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	POWDER, FOR SUSPENSION / ORAL		4441 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		2 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / INTRAVENOUS		1950 mg	Exact identifier — unii candidate 48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
aa72cc66-8257-4185-b563-894032636337			b581311a-4ff9-4574-ba62-218288a59543	2010-09-13	Boxed warning, Adverse reactions	Exact identifier spl id: aa72cc66-8257-4185-b563-894032636337 spl set id: b581311a-4ff9-4574-ba62-218288a59543

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.